Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases

Institution:	1. Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom;3. Division of Gastroenterology, University of Alberta, Edmonton, Canada;4. Department of Medicine 1, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany;6. Department of Gastroenterology and Hepatology, Amsterdam University Medical Centres, Location AMC, Amsterdam, The Netherlands;5. Centre for Liver and Gastroenterology Research, National Institute for Health Research, Birmingham Biomedical Research Centre, Birmingham, United Kingdom;7. Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom;12. Toronto Centre for Liver Disease, University Health Network and University of Toronto, Toronto, Canada;8. First Department of Medicine and Martin Zeitz Centre for Rare Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;10. Division of Gastroenterology and Hepatology, University of California Davis, Sacramento, California;9. Division of Hepatology, University of Miami, Miami, Florida;71. Patient Flow Gastrointestinal Diseases, Patient Area Gastroenterology, Dermatovenerology and Rheumatology, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden;123. Centre for Digestive Diseases, Division of Hepatology, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden;84. Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands;106. Liver Care & Transplantation Services, University of Washington Medical Center, Seattle, Washington;95. Yale Autoimmune and Cholestatic Liver Disease Program, Section of Digestive Diseases, Yale University School of Medicine, New Haven, Connecticut;77. Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University if Vienna, Vienna, Austria;1212. Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;88. Clinic of Gastroenterology and Hepatology, Ospedali Riuniti University Hospital, Ancona, Italy;1010. Division of Hepatology and Liver Transplantation, California Pacific Medical Center, San Francisco, California;99. Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy;771. Department of Statistics, University of Oxford, Oxford, United Kingdom

Abstract:

Keywords:	Cholestatic Liver Disease Ulcerative Colitis Crohn’s Disease Integrin alpha4beta7 ALP"} {"#name":"keyword" "$":{"id":"kwrd0035"} "$$":[{"#name":"text" "_":"alkaline phosphatase ALT"} {"#name":"keyword" "$":{"id":"kwrd0045"} "$$":[{"#name":"text" "_":"alanine transaminase AST"} {"#name":"keyword" "$":{"id":"kwrd0055"} "$$":[{"#name":"text" "_":"aspartate aminotransferase CD"} {"#name":"keyword" "$":{"id":"kwrd0065"} "$$":[{"#name":"text" "_":"Crohn’s disease IBD"} {"#name":"keyword" "$":{"id":"kwrd0075"} "$$":[{"#name":"text" "_":"inflammatory bowel disease IQR"} {"#name":"keyword" "$":{"id":"kwrd0085"} "$$":[{"#name":"text" "_":"interquartile range LT"} {"#name":"keyword" "$":{"id":"kwrd0095"} "$$":[{"#name":"text" "_":"liver transplantation PSC"} {"#name":"keyword" "$":{"id":"kwrd0105"} "$$":[{"#name":"text" "_":"primary sclerosing cholangitis UC"} {"#name":"keyword" "$":{"id":"kwrd0115"} "$$":[{"#name":"text" "_":"ulcerative colitis UDCA"} {"#name":"keyword" "$":{"id":"kwrd0125"} "$$":[{"#name":"text" "_":"ursodeoxycholic acid ULN"} {"#name":"keyword" "$":{"id":"kwrd0135"} "$$":[{"#name":"text" "_":"upper limit of normal
本文献已被 ScienceDirect 等数据库收录！

设为首页 | 免责声明 | 关于勤云 | 加入收藏